Dalian BIO-CHEM Company Limited
603360.SS · SHH
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | CN¥17 | CN¥11 | CN¥11 | CN¥8 |
| - Cash | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| + Debt | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| Enterprise Value | CN¥18 | CN¥12 | CN¥11 | CN¥8 |
| Revenue | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Growth | 2.3% | -33% | 7.8% | – |
| Gross Profit | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 34.7% | 34.9% | 31.5% | 38.5% |
| EBITDA | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 15.1% | 23.9% | 20.1% | 33.2% |
| Net Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 10.8% | 13.9% | 11.2% | 21.9% |
| EPS Diluted | 0.047 | 0.083 | 0.1 | 0.18 |
| % Growth | -42.9% | -17% | -44.4% | – |
| Operating Cash Flow | CN¥0 | CN¥0 | -CN¥0 | CN¥0 |
| Capital Expenditures | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| Free Cash Flow | CN¥0 | CN¥0 | -CN¥0 | -CN¥0 |